Categories:

• Agriculture and Forestry
• Automotive
• Biotechnology and Pharmaceuticals
• Chemicals
• Construction and Maintenance
• Consumer Goods and Services
• Electronics and Electrical
• Energy and Environment
• Food and Related Products
• Industrial Goods and Services
• Information Technology
• Materials
• Real Estate
• Telecommunications
• Textiles and Nonwovens
• Transportation and Logistics

Popular Tags:

• player
• mp4
• mp4 player
• screen
• player screen
• screen mp4
• 4gb
• player 4gb
• 4gb mp4
• card
• slot
• player card
• 18inch
• inch
• 15inch
• inch mp4
• inch player
• flash
• style
• builtin

Home › Pfizer's Ibrance drug slows progression of breast cancer

 

Pfizer's Ibrance drug slows progression of breast cancer

2015-05-30 19:03:57| Biotech - Topix.net

CHICAGO: A Phase III trial of Pfizer Inc's drug Ibrance showed that, in combination with hormone therapy, the drug more than doubled the duration of disease control for women with the most common type of breast cancer. At the time of an interim analysis, patients given Ibrance in combination with AstraZeneca Plc's Faslodex , a widely used treatment to block estrogen, lived an average of 9.2 months before their cancer worsened.

Tags: drug cancer breast progression

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»

07.11 Ahlstroms Climate Targets Validated by SBTi 07.11 Mativ Reports Third Quarter Results 07.11 Lawsuit over FDA's regulatory approval process for carbadox dismissed 07.11 Hurricane Rafael Graphics 07.11 Hurricane Rafael Forecast Discussion Number 16 07.11 Hurricane Rafael Wind Speed Probabilities Number 16 07.11 Hurricane Rafael Forecast Advisory Number 16 07.11 Hurricane Rafael Public Advisory Number 16 More »